difference between cryptocurrency and blockchain Related searches

The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.The personal pension system has been extended to the whole country. On December 12th, the Ministry of Human Resources and Social Security and other five departments issued the Notice on the Full Implementation of the Personal Pension System. Since December 15th, the personal pension system has been extended to the whole country from 36 pilot cities (regions). (Xinhua News Agency)The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.

Zhangjiakou Smart Grid Auto Equity Investment Fund was registered and established. The enterprise search APP shows that recently, Zhangjiakou Smart Grid Auto Equity Investment Fund Partnership (Limited Partnership) was established with a capital contribution of 301 million yuan. Its business scope includes: engaging in equity investment, investment management and asset management with private equity funds. Enterprise investigation shows that the company is jointly owned by Zhangjiakou Industrial Investment Holding Group Co., Ltd. and Zhangjiakou Nanshan Economic Development Zone Construction and Development Co., Ltd.Xinwei launched the Intel Eagle Stream platform 4U8 card server P5500G5H. Recently, Xinwei launched the Intel Eagle Stream platform 4U8 card server P5500G5H, which has the characteristics of leading architecture, super computing power and flexible expansion, and provides strong computing support for different AI applications. Xinwei P5500G5H server can support running hundreds of billions of parameter models. In terms of framework and algorithm, it supports mainstream AI frameworks such as PyTorch, TensorFlow, caffe, mxnet and popular development tools such as DeepSpeed.Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation. On December 12th, Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation, including the cooperation project of Xiong 'an Medical and Industrial Cross Transformation Research Institute of Peking University People's Hospital and the fourth generation semiconductor material doped AlN epitaxial wafer, and many independent innovative projects landed in xiong'an new area. As a national innovation platform, Xiong 'an Center will focus on key tasks such as building a first-class innovation platform, forming a composite innovation team, and improving the innovation and entrepreneurship ecology, and strive to create an important source of independent innovation and original innovation. (CCTV News)

Beijing Haidian Joy City will open on December 21st. According to WeChat official account news of "Beijing Haidian" WeChat, Haidian Joy City, the fourth joy city in Beijing, will open on December 21st. At present, many brands have come to an end, and the merchants in the venue have entered the preparations for opening. It is understood that Haidian Joy City is expected to introduce more than 280 brands.According to court documents, the US Department of Justice asked the court to reject ByteDance and TikTok's request to postpone the law banning applications before January 19.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.